secwatch.observer — SEC 8-K summary
======================================

Issuer:     JUPITER NEUROSCIENCES, INC. (JUNS)
CIK:        0001679628
Form:       8-K
Filed at:   2024-12-04T23:59:59+00:00
Accession:  0001493152-24-048687
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jupiter Neurosciences closes IPO on Nasdaq, raises $11M gross from 2.75M shares at $4.00
--------------------------------------------------------------------------------

- IPO of 2,750,000 common shares priced at $4.00/sh for gross proceeds of $11M.
- Net proceeds to Jupiter are approximately $9.5M after underwriting discounts and expenses.
- Shares began trading on Nasdaq Capital Market on Dec 3, 2024 under ticker JUNS.
- Proceeds earmarked for Phase II trial of JOTROL in Parkinson's, SE Asia initiatives, R&D, license fees, debt repayment, and working capital.
- Dominari Securities acted as lead underwriter; Revere Securities as co-manager.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1679628/000149315224048687/0001493152-24-048687-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1679628/000149315224048687/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-048687

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer